Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 35 results
Author Title [ Type(Asc)] Year
Filters: Author is Falck-Pedersen, E  [Clear All Filters]
Journal Article
Prescott JC, Falck-Pedersen E.  1992.  Varied poly(A) site efficiency in the adenovirus major late transcription unit.. J Biol Chem. 267(12):8175-81.
Peng Y, Falck-Pedersen E, Elkon KB.  2001.  Variation in adenovirus transgene expression between BALB/c and C57BL/6 mice is associated with differences in interleukin-12 and gamma interferon production and NK cell activation.. J Virol. 75(10):4540-50.
Elkon KB, Liu CC, Gall JG, Trevejo J, Marino MW, Abrahamsen KA, Song X, Zhou JL, Old LJ, Crystal RG et al..  1997.  Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors.. Proc Natl Acad Sci U S A. 94(18):9814-9.
Falck-Pedersen E, Logan J, Shenk T, Darnell JE.  1985.  Transcription termination within the E1A gene of adenovirus induced by insertion of the mouse beta-major globin terminator element.. Cell. 40(4):897-905.
Citron B, Falck-Pedersen E, Salditt-Georgieff M, Darnell JE.  1984.  Transcription termination occurs within a 1000 base pair region downstream from the poly(A) site of the mouse beta-globin (major) gene.. Nucleic Acids Res. 12(22):8723-31.
Trevejo JM, Marino MW, Philpott N, Josien R, Richards EC, Elkon KB, Falck-Pedersen E.  2001.  TNF-alpha -dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection.. Proc Natl Acad Sci U S A. 98(21):12162-7.
Gershengorn MC, Heinflink M, Nussenzveig DR, Hinkle PM, Falck-Pedersen E.  1994.  Thyrotropin-releasing hormone (TRH) receptor number determines the size of the TRH-responsive phosphoinositide pool. Demonstration using controlled expression of TRH receptors by adenovirus mediated gene transfer.. J Biol Chem. 269(9):6779-83.
Peng Y, Falck-Pedersen E, Elkon KB.  2000.  Soluble CD8 attenuates cytotoxic T cell responses against replication-defective adenovirus affording transprotection of transgenes in vivo.. J Immunol. 165(3):1470-8.
Mastrangeli A, Harvey BG, Yao J, Wolff G, Kovesdi I, Crystal RG, Falck-Pedersen E.  1996.  "Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype.. Hum Gene Ther. 7(1):79-87.
DeZazzo JD, Falck-Pedersen E, Imperiale MJ.  1991.  Sequences regulating temporal poly(A) site switching in the adenovirus major late transcription unit.. Mol Cell Biol. 11(12):5977-84.
Prescott JC, Liu L, Falck-Pedersen E.  1997.  Sequence-mediated regulation of adenovirus gene expression by repression of mRNA accumulation.. Mol Cell Biol. 17(4):2207-16.
Prescott J, Falck-Pedersen E.  1994.  Sequence elements upstream of the 3' cleavage site confer substrate strength to the adenovirus L1 and L3 polyadenylation sites.. Mol Cell Biol. 14(7):4682-93.
Falck-Pedersen E, Logan J.  1989.  Regulation of poly(A) site selection in adenovirus.. J Virol. 63(2):532-41.
Gulati P, Falck-Pedersen E, Siskind GW.  1989.  Regulation of antibody secretion by hybridoma cells. II. Mechanism of idiotype-induced suppression of antibody secretion by hybridoma cells.. Cell Immunol. 123(2):276-82.
Falck-Pedersen E, Morris PW, Venton DL.  1983.  Regiospecific arylazo substitution into alpha-amanitin with retention of inhibitory properties against eukaryotic class II RNA polymerase.. Int J Pept Protein Res. 21(4):431-9.
Kass-Eisler A, Falck-Pedersen E, Alvira M, Rivera J, Buttrick PM, Wittenberg BA, Cipriani L, Leinwand LA.  1993.  Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo.. Proc Natl Acad Sci U S A. 90(24):11498-502.
Logan J, Falck-Pedersen E, Darnell JE, Shenk T.  1987.  A poly(A) addition site and a downstream termination region are required for efficient cessation of transcription by RNA polymerase II in the mouse beta maj-globin gene.. Proc Natl Acad Sci U S A. 84(23):8306-10.
Yeaman C, Heinflink M, Falck-Pedersen E, Rodriguez-Boulan E, Gershengorn MC.  1996.  Polarity of TRH receptors in transfected MDCK cells is independent of endocytosis signals and G protein coupling.. Am J Physiol. 270(3 Pt 1):C753-62.
Kaner RJ, Worgall S, Leopold PL, Stolze E, Milano E, Hidaka C, Ramalingam R, Hackett NR, Singh R, Bergelson J et al..  1999.  Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.. Am J Respir Cell Mol Biol. 20(3):361-70.
Falck-Pedersen E, Neuman W, Morris PW.  1982.  Interaction of several class II and III RNA polymerases with two families of 7'-substituted alpha-amanitin.. Biochemistry. 21(21):5164-70.
Worgall S, Wolff G, Falck-Pedersen E, Crystal RG.  1997.  Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.. Hum Gene Ther. 8(1):37-44.
Peng Y, Trevejo J, Zhou J, Marino MW, Crystal RG, Falck-Pedersen E, Elkon KB.  1999.  Inhibition of tumor necrosis factor alpha by an adenovirus-encoded soluble fusion protein extends transgene expression in the liver and lung.. J Virol. 73(6):5098-109.
Kass-Eisler A, Falck-Pedersen E, Elfenbein DH, Alvira M, Buttrick PM, Leinwand LA.  1994.  The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer.. Gene Ther. 1(6):395-402.
Miyazawa N, Leopold PL, Hackett NR, Ferris B, Worgall S, Falck-Pedersen E, Crystal RG.  1999.  Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors.. J Virol. 73(7):6056-65.
Falck-Pedersen E, Heinflink M, Alvira M, Nussenzveig DR, Gershengorn MC.  1994.  Expression of thyrotropin-releasing hormone receptors by adenovirus-mediated gene transfer reveals that thyrotropin-releasing hormone desensitization is cell specific.. Mol Pharmacol. 45(4):684-9.